Earlier diagnosis of progressive disease during bevacizumab treatment using O-(2-18F-fluorethyl)-L-tyrosine positron emission tomography in comparison with magnetic resonance imaging.
about
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches.Usefulness of positron emission tomographic studies for gliomas.Imaging in neuro-oncology.
P2860
Earlier diagnosis of progressive disease during bevacizumab treatment using O-(2-18F-fluorethyl)-L-tyrosine positron emission tomography in comparison with magnetic resonance imaging.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Earlier diagnosis of progressive disease during bevacizumab treatment using O-
@nl
Earlier diagnosis of progressi ...... th magnetic resonance imaging.
@en
type
label
Earlier diagnosis of progressive disease during bevacizumab treatment using O-
@nl
Earlier diagnosis of progressi ...... th magnetic resonance imaging.
@en
prefLabel
Earlier diagnosis of progressive disease during bevacizumab treatment using O-
@nl
Earlier diagnosis of progressi ...... th magnetic resonance imaging.
@en
P2093
P50
P356
P1476
Earlier diagnosis of progressi ...... ith magnetic resonance imaging
@en
P2093
Marion Rapp
Michael Sabel
Veronika Dunkl
P304
P356
10.2310/7290.2013.00051
P577
2013-07-01T00:00:00Z